Business Wire

NY-CLOUDREACH

28.1.2021 15:02:31 CET | Business Wire | Press release

Share
Cloudreach Launches DevOps as a Service to Provide Flexible Support for Organizations Driving IT Transformation

Cloudreach , the leading independent multi-cloud services company, today announced the launch of Cloudreach DevOps as a Service. This new offering combines Cloudreach development and operations, making them available ‘as a Service’ via a simple and flexible subscription model. DevOps as a Service is the first of its kind in the market, and fundamentally changes how cloud IT services are consumed to make it easy for enterprises to adopt cloud native technologies and practices.

Dave Chapman, Head of Strategy and Professional Services at Cloudreach, said: “Cloudreach DevOps as a Service brings a DevOps and cloud engineering skill set to any enterprise, whether they are new to the cloud or far along their modernization journey. Companies that undergo cloud transformation are better able to adapt to disruption, explore and innovate faster. This service helps technology leaders get the right skills in place, at the right time, and scale up and down to suit their changing requirements.”

Cloud acceleration
DevOps is a set of practices that combines software development and IT operations, removing the barriers between these traditionally siloed teams. Under a DevOps model, development and operations teams work together across the entire software application life cycle, from development and test through deployment to operations.

More than a decade after the introduction of cloud computing, many enterprises still find themselves suffering from the symptoms of legacy IT and legacy partners. Cloudreach DevOps as a Service makes cloud outsourcing easy by providing flexible engineering squads as a monthly subscription service. The new offering is designed to help technology leaders accelerate their cloud initiatives, embrace true DevOps within their teams, and help their organizations become more cloud native.

Cloudreach DevOps as a Service provides a core DevOps team that can be augmented to perform architecture, platform development, data engineering, application UX and product management roles, all as a unified service. As business priorities or backlogs change, the flexible nature of the service means customers can swap out squad members and scale the team up and down as needed, within a single statement of work. The minimum squad size includes two resources and 80 hours per month, with a minimum contract commitment of three months.

Cloudreach squads have a radical focus on trend improvement and platform evolution. They can help launch new products, accelerate and scale business initiatives, facilitate stronger collaboration with digital teams, or support key applications and infrastructure.

James Dunn, Head of Cloud Platform Development at Cloudreach, said: “Over its 10-year history, Cloudreach has delivered some of the largest and most successful cloud engineering projects in the world. Now we are bringing Cloudreach's cloud native expertise to market in a flexible subscription model.”

- ENDS -

About Cloudreach
Cloudreach is a leading independent cloud services company. Our mission is to deliver the promise of cloud and drive extraordinary value for our customers. Cloudreach helps enterprises win competitive advantage through successful cloud transformation.

With more than 10 years of cloud native experience, we've built an unmatched depth and breadth of expertise in cloud technologies and their application to business. For more information about our services, visit cloudreach.com .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and

Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release

Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit

Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse

Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig

PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release

Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli

Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release

Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye